+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

The HPAPI industry is expanding at a healthy rate due to development and manufacturing of drugs for anti-cancer and chronic disorders. Despite of challenges in designing multiproduct facilities, robust containment, safety & toxicology issues, there are many pharmaceutical firms coming up with their new research pipeline of drugs.

After our successful inaugural 2017 edition, MarketsandMarkets is proud to announce the 2nd Annual High Potent Medicines Conference to be held on 29th-30th May, 2018 in Frankfurt, Germany. The focus of this year’s conference would address the issues in process development, scale-up, regulatory updates, containment, handling, cleaning validation and toxicology of highly potent compounds. The conference would be addressing the major challenges in the HPAPI manufacturing industry where the leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.

Click here to view post-show report of the High Potent Medicines Conference

conference Registration Form



Industry Delegate €1300
Solution Provider Delegate€1900


Key Highlights:

  • Aseptic processing and production of highly potent compounds
  • Risk management and monitoring scale-up processes for hipo products
  • Regulatory updates in GMP regulations
  • Changes in import regulations after USA-EU mutual recognition agreement
  • Requirements and strategies to ensure Data Integrity
  • Managing the risk of cross contamination of HPAPI’s
  • Robust and reliable containment solutions
  • Medical surveillance/monitoring workers programs
  • Cleaning Validation of highly potent products

For more information on the agenda of the conference, you can write to us at amit.shelke@marketsandmarkets.com




Who Should Attend ?

From pharmaceutical manufacturing and Biopharmaceutical manufacturing

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in the following departments;


  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Quality
  • Regulatory
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer
  • Environmental, Health & Safety (HSE)
  • Occupational Toxicology
  • Industrial Hygiene
  • New Products
  • Product Quality
  • Innovations
  • Regulatory
  • Validation
  • Formulation Development
  • External Supply

Advisory Panel

  • Ester Lovšin Barle, Head, Health Hazard Assessment, Lonza
  • Juergen Knoebel, Head, Small Molecules Quality Operations, Roche, Switzerland
  • Ildiko Ziegler, Validation Expert, Gedeon Richter, Hungary
  • Richard Denk, Head, Sales Containment, SKAN AG, Switzerland


  • Ester Lovšin Barle

    Corporate Toxicologist, Lonza, Switzerland
  • Ildiko Ziegler

    Validation Expert, Gedeon Richter, Hungary
  • Richard Denk

    Head, Sales Containment, SKAN AG, Switzerland
  • Andreas Schreiner

    Manufacturing Science & Technology (MS&T), Validation Head, Novartis, Switzerland
  • Ulrich Scholz

    Head, Scale Up and Processing, Bayer, Germany
  • Toral Mehta

    Head Industrial Hygiene and Containment, Health, Safety, Environment, Novartis, Austria
  • Firelli Alonso

    Senior Director, External Supply, Biotherapeutics, Pfizer, USA
  • Yossi Shapira

    Associate Director, MS&T S.M.E, Teva, Israel
  • Claudia Sehner

    Principal Scientist, Boehringer-Ingelheim, Germany
  • Angela Zhou

    Senior Sourcing Manager, Genentech, USA
  • David O’Connell

    Director, Scientific Affairs PCI Services, UK
  • Chris Seaman

    Managing Toxicologist, SafeBridge, UK
  • Stefano Butti

    Technical Sales Director, Food Pharma Systems, Italy
  • Michel Crevoisier

    Senior QA and GMP Expert, Ex-Novartis Consultant, Switzerland
  • Gerald Kindermann

    QA and GMP Compliance Lead, Roche, Switzerland


Silver Sponsor

SK Biotek Ireland
SK biotek Ireland

SK biotek Ireland, Swords Campus is a multi-purpose facility with 20+ years of experience in High Potency API manufacturing OEB Class 5 (1-0.1 µg/m3.shift) providing bespoke development from early clinical phases to commercial manufacture (batch sizes 1kg to 50kg+).  Our expertise in process research and development, analytical laboratories, plant scale chromatography, hydrogenation, operational excellence, second to none audit record, RTP and STP, which makes us your an ideal partner for all your custom manufacturing needs



Food Pharma Systems

FPS is specialized in fine size reduction equipment and containment systems for many industrial applications.Our micronization technology considers both fluid jet mills and mechanical pin mills to assure the widest fine grinding capabilities. FPS process experts are available to define the more suitable configuration for your fine grinding needs.
 FPS micronization technology is the result of a study which has brought to the development of a wide range of jet mills. F.P.S. Jet mills offer the best performances on the market. They guarantee a constant temperature process, no moving parts and easy cleaning and mounting.Containment is a general approach for FPS, allowing us to propose solutions starting from clean rooms up to isolators for sterile or HPAPI manufacturing needs. FPS Test center is equipped for the execution of technical trials with your products using our jet mills in different configurations. FPS Containment systems (Gloveboxes, Isolators, Laminar flow units and Cleanrooms) are engineered and manufactured according to the customer process requirements.  Our systems guarantee high containment level and full safety for the operator and product. All the operations can be performed, involving product charging, sampling, processing, filling, dispensing, final discharge, controlling and recording also.

PCA Pharma ServicesPCI Pharma Services 

PCI Pharma Services is an integrated full service provider offering unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialisation, delivering speed-to-market and commercial success for our customers. PCI has over thirty five years’ experience in providing integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry.  For several decades PCI has successfully developed and manufactured solid dose high potent products to high standards of quality and safety.


MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation/workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on- One Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty-minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact us at events@marketsandmarkets.com

Media partners


Swiss Biotech Association

The Swiss Biotech Association 

The Swiss Biotech Association represents the interests of the biotech sector, supports the entrepreneurship of biotech companies, and generates value for them through the following activities:

  • Development of optimal framework conditions for the biotech sector
  • Networking of stakeholders at national and international level
  • Dissemination of accomplishments in biotechnology
  • Collaboration with strategic partners

biopharmachem Ireland

BioPharmaChem Ireland

BioPharmaChem Ireland is the biopharma, pharma and chemicals sector association of Ibec. Representing multinational and indigenous members, our strategy is to ensure Ireland becomes the global centre of excellence for innovation and development. We aim to achieve this through our advocacy work with national and international agencies or governments, tackling specific issues affecting the industry through our working groups and building a future talent pipeline.



2nd Annual High Potent Medicines Conference will be held at the Dorint Hotels and Resorts

Dorint Hotels and Resorts
Main Taunus Zentrum
Frankfurt, Germany

About the Hotel

The Dorint Hotels & Resorts invite you to enjoy a relaxing, exciting, pampered, sporting and active holiday in the most attractive regions of Germany and Switzerland – on your own, as a couple or with the whole family. Whether our conference hotels in central location, our wellness hotels to enjoy and relax or our holiday apartments at the sea or in the countryside – you'll make a find at the Dorint Hotels & Resorts.

For further information, please contact:

Email: events@marketsandmarkets.com